Drug Approval | November 19, 2021
Natco launches Tipanat tablets in India
It is used for the treatment of advanced colorectal and gastric cancer
It is used for the treatment of advanced colorectal and gastric cancer
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
Nelarabine is in a class of medications called antimetabolites
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)
EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
Subscribe To Our Newsletter & Stay Updated
